State Street’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,805
| Closed | -$35.2K | – | 4921 |
|
|
2022
Q4 | $35.2K | Hold |
10,805
| – | – | ﹤0.01% | 4634 |
|
|
2022
Q3 | $32K | Hold |
10,805
| – | – | ﹤0.01% | 4756 |
|
|
2022
Q2 | $27K | Sell |
10,805
-1
| -0% | -$5 | ﹤0.01% | 4836 |
|
|
2022
Q1 | $87K | Hold |
10,806
| – | – | ﹤0.01% | 4684 |
|
|
2021
Q4 | $144K | Hold |
10,806
| – | – | ﹤0.01% | 4478 |
|
|
2021
Q3 | $471K | Sell |
10,806
-5,875
| -35% | -$253K | ﹤0.01% | 4002 |
|
|
2021
Q2 | $697K | Sell |
16,681
-43,547
| -72% | -$1.91M | ﹤0.01% | 3732 |
|
|
2021
Q1 | $2.92M | Sell |
60,228
-2,642
| -4% | -$154K | ﹤0.01% | 3279 |
|
|
2020
Q4 | $6.17M | Sell |
62,870
-1,649
| -3% | -$145K | ﹤0.01% | 2862 |
|
|
2020
Q3 | $4.45M | Buy |
64,519
+4,592
| +8% | +$401K | ﹤0.01% | 2840 |
|
|
2020
Q2 | $6.33M | Buy |
59,927
+10,067
| +20% | +$1.2M | ﹤0.01% | 2644 |
|
|
2020
Q1 | $4.43M | Buy |
49,860
+7,356
| +17% | +$876K | ﹤0.01% | 2687 |
|
|
2019
Q4 | $4.85M | Buy |
42,504
+5,630
| +15% | +$423K | ﹤0.01% | 2863 |
|
|
2019
Q3 | $2.28M | Buy |
36,874
+3,381
| +10% | +$271K | ﹤0.01% | 3171 |
|
|
2019
Q2 | $2.61M | Buy |
33,493
+6,361
| +23% | +$722K | ﹤0.01% | 3133 |
|
|
2019
Q1 | $3.66M | Buy |
27,132
+406
| +2% | +$42.7K | ﹤0.01% | 2902 |
|
|
2018
Q4 | $2.14M | Sell |
26,726
-913
| -3% | -$90K | ﹤0.01% | 3094 |
|
|
2018
Q3 | $2.9M | Buy |
27,639
+1,072
| +4% | +$102K | ﹤0.01% | 3103 |
|
|
2018
Q2 | $2.66M | Buy |
26,567
+160
| +0.6% | +$18.1K | ﹤0.01% | 3140 |
|
|
2018
Q1 | $3.33M | Buy |
26,407
+30
| +0.1% | +$4.68K | ﹤0.01% | 2966 |
|
|
2017
Q4 | $4.4M | Sell |
26,377
-51,265
| -66% | -$13.1M | ﹤0.01% | 2848 |
|
|
2017
Q3 | $24.5M | Buy |
77,642
+12,423
| +19% | +$3.92M | ﹤0.01% | 1884 |
|
|
2017
Q2 | $19.4M | Buy |
65,219
+64,114
| +5,802% | +$17.1M | ﹤0.01% | 2016 |
|
|
2017
Q1 | $255K | Buy |
+1,105
| New | +$191K | ﹤0.01% | 3479 |
|
|
2016
Q2 | – | Sell |
-5,553
| Closed | -$632K | – | 3789 |
|
|
2016
Q1 | $632K | Buy |
5,553
+875
| +19% | +$99.1K | ﹤0.01% | 3307 |
|
|
2015
Q4 | $717K | Sell |
4,678
-5
| -0.1% | -$750 | ﹤0.01% | 3278 |
|
|
2015
Q3 | $510K | Buy |
4,683
+524
| +13% | +$67.9K | ﹤0.01% | 3328 |
|
|
2015
Q2 | $595K | Buy |
4,159
+163
| +4% | +$37.8K | ﹤0.01% | 3339 |
|
|
2015
Q1 | $1.31M | Buy |
3,996
+790
| +25% | +$281K | ﹤0.01% | 3167 |
|
|
2014
Q4 | $1.29M | Buy |
+3,206
| New | +$837K | ﹤0.01% | 3200 |
|
Other funds holding CALA
State Street's CALA Position: Q1 2023 in Review
State Street sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 10,805 shares — an estimated $35.2K sold.
State Street first reported a position in CALA in Q4 2014 and held it in 30 quarters. The position peaked at $24.5M in Q3 2017. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.
- State Street reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
- State Street sold 10,805 Calithera Biosciences, Inc shares in Q1 2023, an estimated $35.2K.
- State Street first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 30 quarters.
- State Street's Calithera Biosciences, Inc position peaked at $24.5M in Q3 2017.
- 2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.
Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.